Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roerig is a historical and still-referenced Pfizer pharmaceutical business unit originating from J.B. Roerig and Company, which specialized in nutritional supplements before being acquired by Pfizer. Within Pfizer, Roerig has functioned as a commercial pharmaceutical division associated with the marketing, distribution, and regulatory holding of approved drug products rather than as a standalone R&D biotech company. Public records and FDA notices continue to reference "Roerig Division of Pfizer Inc." as an applicant or sponsor name for marketed products. As a result, Roerig is best understood as an acquired legacy Pfizer division tied to commercialized healthcare products, not an independent modern pipeline-stage biotech enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roerig.